Abstract
Heparin chips were employed to characterize the binding profiles of three heparin‐binding growth factors (FGF‐1, FGF‐2, and FGF‐4). The results, presented in the Full Paper by P. H. Seeberger et al. on page 8664 ff., demonstrate the potential of synthetic heparin‐oligosaccharide microarrays to elucidate the role of defined heparin sequences in biological processes, creating an opportunity for the discovery of novel therapeutic interventions for a variety of disease states. (The protein in the cover picture was taken from the RSCB Protein Databank (1FGA.pdb).)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
